Cargando…
A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids
Chagas disease and Leishmaniasis are neglected endemic protozoan diseases recognized as public health problems by the World Health Organization. These diseases affect millions of people around the world however, efficient and low-cost treatments are not available. Different steroid molecules with an...
Autores principales: | Aguilera, Elena, Perdomo, Cintya, Espindola, Alejandra, Corvo, Ileana, Faral-Tello, Paula, Robello, Carlos, Serna, Elva, Benítez, Fátima, Riveros, Rocío, Torres, Susana, Vera de Bilbao, Ninfa I., Yaluff, Gloria, Alvarez, Guzmán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832524/ https://www.ncbi.nlm.nih.gov/pubmed/31652542 http://dx.doi.org/10.3390/molecules24203800 |
Ejemplares similares
-
Preclinical Studies in Anti-Trypanosomatidae Drug Development
por: Perdomo, Cintya, et al.
Publicado: (2021) -
Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
por: Aguilera, Elena, et al.
Publicado: (2018) -
In Vivo Anti-Trypanosoma cruzi Activity of Hydro-Ethanolic Extract and Isolated Active Principles from Aristeguietia glutinosa and Mechanism of Action Studies
por: Varela, Javier, et al.
Publicado: (2014) -
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease
por: Aguilera, Elena, et al.
Publicado: (2022) -
The Tritryps Comparative Repeatome: Insights on Repetitive Element Evolution in Trypanosomatid Pathogens
por: Pita, Sebastián, et al.
Publicado: (2019)